BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35347291)

  • 1. Oral nicotinamide for non-melanoma skin cancers: A review.
    Hunt SV; Jamison A; Malhotra R
    Eye (Lond); 2023 Apr; 37(5):823-829. PubMed ID: 35347291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
    N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide for skin cancer chemoprevention.
    Damian DL
    Australas J Dermatol; 2017 Aug; 58(3):174-180. PubMed ID: 28321860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis.
    Tosti G; Pepe F; Gnagnarella P; Silvestri F; Gaeta A; Queirolo P; Gandini S
    Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study.
    Drago F; Ciccarese G; Cogorno L; Calvi C; Marsano LA; Parodi A
    Eur J Dermatol; 2017 Aug; 27(4):382-385. PubMed ID: 28468736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral nicotinamide and actinic keratosis: a supplement success story.
    Kim B; Halliday GM; Damian DL
    Curr Probl Dermatol; 2015; 46():143-9. PubMed ID: 25561219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?
    Minocha R; Damian DL; Halliday GM
    Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):5-12. PubMed ID: 28681504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.
    Snaidr VA; Damian DL; Halliday GM
    Exp Dermatol; 2019 Feb; 28 Suppl 1():15-22. PubMed ID: 30698874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis.
    Mainville L; Smilga AS; Fortin PR
    J Cutan Med Surg; 2022; 26(3):297-308. PubMed ID: 35134311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide for skin cancer chemoprevention: effects of nicotinamide on melanoma in vitro and in vivo.
    Malesu R; Martin AJ; Lyons JG; Scolyer RA; Chen AC; McKenzie CA; Madore J; Halliday GM; Damian DL
    Photochem Photobiol Sci; 2020 Feb; 19(2):171-179. PubMed ID: 31942903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide and the skin.
    Chen AC; Damian DL
    Australas J Dermatol; 2014 Aug; 55(3):169-75. PubMed ID: 24635573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
    Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
    Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials.
    Surjana D; Halliday GM; Martin AJ; Moloney FJ; Damian DL
    J Invest Dermatol; 2012 May; 132(5):1497-500. PubMed ID: 22297641
    [No Abstract]   [Full Text] [Related]  

  • 14. New and current preventive treatment options in actinic keratosis.
    Arenberger P; Arenbergerova M
    J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():13-17. PubMed ID: 28805940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is nicotinamide a sustainable therapy for resistant actinic keratoses?
    Paugam C; Dréno B
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e624-e626. PubMed ID: 32311791
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral nicotinamide: The role in skin cancer chemoprevention.
    Giacalone S; Spigariolo CB; Bortoluzzi P; Nazzaro G
    Dermatol Ther; 2021 May; 34(3):e14892. PubMed ID: 33595161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer.
    Boeri M; Skelsey MK; Schiro JA; Dozier SE; Glinert R; Okun MM
    J Dermatolog Treat; 2023 Dec; 34(1):2247105. PubMed ID: 37587862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health economic evaluation of non-melanoma skin cancer and actinic keratosis.
    Higashi MK; Veenstra DL; Langley PC
    Pharmacoeconomics; 2004; 22(2):83-94. PubMed ID: 14731050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin.
    Surjana D; Halliday GM; Damian DL
    Carcinogenesis; 2013 May; 34(5):1144-9. PubMed ID: 23349012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide and Nonmelanoma Skin Cancers.
    Jamison A; Malhotra R
    Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):304-305. PubMed ID: 35170567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.